MED vs SCI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 04, 2026
MED
SCI
Investment Advisor Scores
SCI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MED | SCI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.4844 | 20.3252 | MED |
| PEG Ratio | 0.972 | 1.694 | MED |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -34.3% | 3.6% | SCI |
| Earnings Growth | -87.2% | 4.7% | SCI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 50.5/100 | 55.0/100 | SCI |
| Profit Margin | -5.8% | 12.3% | SCI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MED
NeutralMixed signals - no dominant trend phase, RSI 72
SCI
NeutralMixed signals - no dominant trend phase, RSI 68
Fundamentals Snapshot
| Metric | MED | SCI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -16.5 | 18.7 |
| Trailing P/E | — | 22.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.3% | 0.0% |
| Gross Margin | 0.7% | 0.3% |
| Operating Margin | -0.1% | 0.2% |
| EPS | -1.82 | 3.83 |
| Dividend Yield | — | 0.02% |